Scholars Central

Research articlePublished 14 Jul 2016

EARLY EXPERIENCE WITH CT-GUIDED CORE BIOPSY OF LUNG TUMORS: DOES SIZE PREDICT DIAGNOSTIC ACCURACY AND COMPLICATION RATE?

Authors: Shahnawaz Ansari M.D., David Schwartzberg M.D., Ryane Panasiti M.D., Utkarsh Anil B.A.

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Lung cancer remains the leading cause of cancer-related deaths and is expected to increase over the next decade. The World Health Organization and the National Comprehensive Cancer Network (NCCN) hav e advocated a low dose computed tomography (LDCT) scan of the chest for individuals at high risk for lung cancer3. With the proliferation in CT scans performed annually, there has been a corresponding increase in lung nodules identification resulting in an increase in invasive procedures to obtain a tissue diagnosis8. Given the increasing number of sub-centimeter lung nodules detected, this pilot study sought to determine if there is a size limit where a successful biopsy is outweighed by the potential risks, i.e. the risk of clinically significant pneumothorax. A retrospective review of CT-guided core lung biopsies performed on 98 patients between January 2013 and January 2015 was performed. The diagnosis and pneumothorax rates were analyzed for 5 cm pulmonary lesions. The presence of clinically significant pneumothorax (requiring tube thoracostomy) was obtained from the patient Electronic Medical Record (EMR). The overall diagnosis and pneumothorax rates were 94.0% and 7.0% respectively. The diagnosis rate was 87.5% for 5 cm pulmonary lesions. The clinically significant pneumothorax rate was 12.5% for 5 cm pulmonary lesions. Our findings show a high level of diagnostic accuracy for core biopsies of lung tumors of all sizes, including sub-centimeter lung nodules while the clinically significant pneumothorax rate remained unchanged. Given this data, we believe core biopsy of small (<1cm) pulmonary nodules can be performed without a significant rise in the rate of clinically significant pneumothorax, providing for earlier detection and treatment of lung carcinoma. Keywords: Lung cancer, Biopsy, pneumothorax.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Harmonized Research in Medical and Health Science.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Harmonized Research in Medical and Health Science
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Shahnawaz Ansari M.D.”
  • BylineArticles whose byline prints “David Schwartzberg M.D.”
  • BylineArticles whose byline prints “Ryane Panasiti M.D.”
  • BylineArticles whose byline prints “Utkarsh Anil B.A.”